REMIX | VLSCX | REMIX / VLSCX | |
Total Expense Ratio | 1.51 | 3.03 | 50% |
Annual Report Gross Expense Ratio | 1.64 | 3.21 | 51% |
Fund Existence | 5 years | 7 years | - |
Gain YTD | -9.397 | 2.228 | -422% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 813M | 48.4M | 1,680% |
Annual Yield % from dividends | 5.96 | 0.00 | - |
Returns for 1 year | -10.11 | -0.18 | 5,578% |
Returns for 3 years | -2.72 | 15.77 | -17% |
Returns for 5 years | 43.29 | 16.17 | 268% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JFNAX | 65.07 | -0.41 | -0.63% |
Janus Henderson Global Life Sciences A | |||
VIGIX | 215.36 | -2.91 | -1.33% |
Vanguard Growth Index Institutional | |||
GFCUX | 22.38 | -0.31 | -1.37% |
Goldman Sachs Enhanced U.S. Equity R6 | |||
WBCIX | 15.70 | -0.27 | -1.69% |
William Blair Small-Mid Cap Core I | |||
GTILX | 27.45 | -0.50 | -1.79% |
Glenmede Disciplined USGrEqPtf InstlShrs |